{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:12:57Z","timestamp":1791202377147,"version":"4.2.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T00:00:00Z","timestamp":1452556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s12072-015-9691-4","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T17:55:10Z","timestamp":1452621310000},"page":"424-435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Advances in the management of HIV\/HCV coinfection"],"prefix":"10.1007","volume":"10","author":[{"given":"Mattias","family":"Mandorfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schwabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Peck-Radosavljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,12]]},"reference":[{"key":"9691_CR1","unstructured":"WHO. Global epidemiology: HIV\/AIDS Department. 2014 (16 Nov 2015). http:\/\/www.who.int\/entity\/hiv\/data\/2014_epi_core.ppt?ua=1"},{"key":"9691_CR2","unstructured":"WHO. Fact sheet HIV\/AIDS 2015 (16 Nov 2015). http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en\/"},{"issue":"1 Suppl","key":"9691_CR3","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014;61(1 Suppl):S45\u2013S57","journal-title":"J Hepatol"},{"key":"9691_CR4","unstructured":"WHO. Fact sheet hepatitis C 2015 (16 Nov 2015). http:\/\/www.who.int\/mediacentre\/factsheets\/fs164_apr2014\/en\/"},{"issue":"Supplement 1","key":"9691_CR5","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","volume":"44","author":"MJ Alter","year":"2006","unstructured":"Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006;44(Supplement 1):S6\u2013S9","journal-title":"J Hepatol"},{"issue":"2","key":"9691_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0032-1316473","volume":"32","author":"M Puoti","year":"2012","unstructured":"Puoti M, Moioli MC, Travi G, Rossotti R. The burden of liver disease in human immunodeficiency virus-infected patients. Semin Liver Dis 2012;32(2):103\u2013113","journal-title":"Semin Liver Dis"},{"issue":"11","key":"9691_CR7","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/liv.12848","volume":"35","author":"C Boesecke","year":"2015","unstructured":"Boesecke C, Grint D, Soriano V, et al. Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected? Liver Int 2015;35(11):2384\u20132391","journal-title":"Liver Int"},{"issue":"10","key":"9691_CR8","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/cid\/cis694","volume":"55","author":"G Wandeler","year":"2012","unstructured":"Wandeler G, Gsponer T, Bregenzer A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis 2012;55(10):1408\u20131416","journal-title":"Clin Infect Dis"},{"issue":"5","key":"9691_CR9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","volume":"136","author":"T Laar van de","year":"2009","unstructured":"van de Laar T, Pybus O, Bruisten S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 2009;136(5):1609\u20131617","journal-title":"Gastroenterology"},{"issue":"6","key":"9691_CR10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/gut.2010.217166","volume":"60","author":"EC Thomson","year":"2011","unstructured":"Thomson EC, Fleming VM, Main J, et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut 2011;60(6):837\u2013845","journal-title":"Gut"},{"issue":"9","key":"9691_CR11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/cid\/civ562","volume":"61","author":"EC Seaberg","year":"2015","unstructured":"Seaberg EC, Witt MD, Jacobson LP, et al. Spontaneous clearance of the hepatitis C virus among men who have sex with men. Clin Infect Dis 2015;61(9):1381\u20131388","journal-title":"Clin Infect Dis"},{"issue":"17","key":"9691_CR12","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e32834bac44","volume":"25","author":"FA Lambers","year":"2011","unstructured":"Lambers FA, Prins M, Thomas X, et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS 2011;25(17):F21\u2013F27","journal-title":"AIDS"},{"key":"9691_CR13","unstructured":"Lundgren JD, Gatell JM, Rockstroh JK, Furrer H. European AIDS Clinical Society (EACS) Guidelines Version 8.0: European AIDS Clinical Society (EACS); 2015 (16 Nov 2015). http:\/\/www.eacsociety.org\/files\/2015_eacsguidelines_8.0-english_revised-20151104.pdf"},{"issue":"12","key":"9691_CR14","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/cid\/ciu699","volume":"59","author":"T Reiberger","year":"2014","unstructured":"Reiberger T. Acute hepatitis C virus infection in HIV-infected men who have sex with men: should we change our screening practice? Clin Infect Dis 2014;59(12):1694\u20131695","journal-title":"Clin Infect Dis"},{"issue":"1","key":"9691_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/liv.12639","volume":"35","author":"P Cacoub","year":"2015","unstructured":"Cacoub P, Dabis F, Costagliola D, et al. Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France. Liver Int 2015;35(1):65\u201370","journal-title":"Liver Int"},{"issue":"4","key":"9691_CR16","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","volume":"30","author":"Y Benhamou","year":"1999","unstructured":"Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999;30(4):1054\u20131058","journal-title":"Hepatology"},{"issue":"4","key":"9691_CR17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/321909","volume":"33","author":"CS Graham","year":"2001","unstructured":"Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001;33(4):562\u2013569","journal-title":"Clin Infect Dis"},{"issue":"6","key":"9691_CR18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2893.2009.01197.x","volume":"17","author":"T Reiberger","year":"2010","unstructured":"Reiberger T, Ferlitsch A, Sieghart W, et al. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension. J Viral Hepat 2010;17(6):400\u2013409","journal-title":"J Viral Hepat"},{"issue":"12","key":"9691_CR19","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/cid\/cis289","volume":"54","author":"MW Hull","year":"2012","unstructured":"Hull MW, Rollet K, Odueyungbo A, et al. Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2012;54(12):1798\u20131805","journal-title":"Clin Infect Dis"},{"issue":"6","key":"9691_CR20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/cid\/cis1017","volume":"56","author":"M Mandorfer","year":"2013","unstructured":"Mandorfer M, Reiberger T, Payer BA, Peck-Radosavljevic M. The influence of portal pressure on the discordance between absolute CD4+ cell count and CD4+ cell percentage in HIV\/hepatitis C virus-coinfected patients. Clin Infect Dis 2013;56(6):904\u2013905","journal-title":"Clin Infect Dis"},{"issue":"3","key":"9691_CR21","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/liv.12615","volume":"35","author":"M Mandorfer","year":"2015","unstructured":"Mandorfer M, Payer BA, Schwabl P, et al. Revisiting liver disease progression in HIV\/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3. Liver Int 2015;35(3):876\u2013885","journal-title":"Liver Int"},{"issue":"4","key":"9691_CR22","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.23136","volume":"50","author":"J Macias","year":"2009","unstructured":"Macias J, Berenguer J, Japon MA, et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus\/hepatitis C virus. Hepatology 2009;50(4):1056\u20131063","journal-title":"Hepatology"},{"issue":"4","key":"9691_CR23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.2012.7844","volume":"308","author":"BN Limketkai","year":"2012","unstructured":"Limketkai BN, Mehta SH, Sutcliffe CG, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV\/HCV. JAMA 2012;308(4):370\u2013378","journal-title":"JAMA"},{"issue":"5","key":"9691_CR24","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2015.06.034","volume":"63","author":"JE Arends","year":"2015","unstructured":"Arends JE, Lieveld FI, Boeijen LL, et al. Natural history and treatment of HCV\/HIV coinfection: is it time to change paradigms? J Hepatol 2015;63(5):1254\u20131262","journal-title":"J Hepatol"},{"key":"9691_CR25","unstructured":"WHO. Consolidated ARV guidelines, June 2013. 2013 (16 Nov 2015). http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/en\/"},{"issue":"10","key":"9691_CR26","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/gutjnl-2011-300749","volume":"61","author":"L Serfaty","year":"2012","unstructured":"Serfaty L, Forns X, Goeser T, et al. Insulin resistance and response to telaprevir plus peginterferon alpha and ribavirin in treatment-naive patients infected with HCV genotype 1. Gut 2012;61(10):1473\u20131480","journal-title":"Gut"},{"issue":"14","key":"9691_CR27","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/QAD.0b013e32835612ce","volume":"26","author":"MW Hull","year":"2012","unstructured":"Hull MW, Rollet K, Moodie EE, et al. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV\/hepatitis C virus-coinfected patients. AIDS 2012;26(14):1789\u20131794","journal-title":"AIDS"},{"issue":"12","key":"9691_CR28","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/gut.2010.234666","volume":"60","author":"S Abramovitch","year":"2011","unstructured":"Abramovitch S, Dahan-Bachar L, Sharvit E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011;60(12):1728\u20131737","journal-title":"Gut"},{"issue":"3","key":"9691_CR29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","volume":"153","author":"N Ding","year":"2013","unstructured":"Ding N, Yu RT, Subramaniam N, et al. A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013;153(3):601\u2013613","journal-title":"Cell"},{"issue":"2","key":"9691_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/QAD.0b013e32835aa161","volume":"27","author":"M Mandorfer","year":"2013","unstructured":"Mandorfer M, Reiberger T, Payer BA, et al. Low vitamin D levels are associated with impaired virologic response to PEGIFN\u00a0+\u00a0RBV therapy in HIV-hepatitis C virus coinfected patients. AIDS 2013;27(2):227\u2013232","journal-title":"AIDS"},{"issue":"2","key":"9691_CR31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jinf.2012.10.025","volume":"66","author":"M Guzman-Fulgencio","year":"2013","unstructured":"Guzman-Fulgencio M, Berenguer J, Garcia-Alvarez M, et al. IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus. J Infect 2013;66(2):170\u2013178","journal-title":"J Infect."},{"issue":"4","key":"9691_CR32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/hep.25791","volume":"56","author":"J Macias","year":"2012","unstructured":"Macias J, Berenguer J, Japon MA, et al. Hepatic steatosis and steatohepatitis in human immunodeficiency virus\/hepatitis C virus-coinfected patients. Hepatology 2012;56(4):1261\u20131270","journal-title":"Hepatology"},{"issue":"4","key":"9691_CR33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20626","volume":"41","author":"JA Pineda","year":"2005","unstructured":"Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005;41(4):779\u2013789","journal-title":"Hepatology"},{"issue":"5","key":"9691_CR34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","volume":"58","author":"T Reiberger","year":"2013","unstructured":"Reiberger T, Ferlitsch A, Payer BA, et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol 2013;58(5):911\u2013921","journal-title":"J Hepatol"},{"issue":"5","key":"9691_CR35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/QAI.0b013e31820ef408","volume":"56","author":"MM Oca Arjona de","year":"2011","unstructured":"de Oca Arjona MM, Marquez M, Soto MJ, et al. Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality. J Acquir Immune Defic Syndr 2011;56(5):420\u2013427","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"9691_CR36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1086\/603559","volume":"49","author":"H Kovari","year":"2009","unstructured":"Kovari H, Ledergerber B, Peter U, et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis 2009;49(4):626\u2013635","journal-title":"Clin Infect Dis"},{"issue":"5","key":"9691_CR37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/infdis\/jit412","volume":"209","author":"ND Parikh","year":"2014","unstructured":"Parikh ND, Martel-Laferriere V, Kushner T, et al. Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm. J Infect Dis 2014;209(5):734\u2013738","journal-title":"J Infect Dis"},{"issue":"1","key":"9691_CR38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1572-0241.2001.03374.x","volume":"96","author":"J Garcia-Samaniego","year":"2001","unstructured":"Garcia-Samaniego J, Rodriguez M, Berenguer J, et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001;96(1):179\u2013183","journal-title":"Am J Gastroenterol"},{"issue":"17","key":"9691_CR39","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200411190-00009","volume":"18","author":"M Puoti","year":"2004","unstructured":"Puoti M, Bruno R, Soriano V, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004;18(17):2285\u20132293","journal-title":"AIDS"},{"issue":"4","key":"9691_CR40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2007.06.010","volume":"47","author":"N Brau","year":"2007","unstructured":"Brau N, Fox RK, Xiao P, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007;47(4):527\u2013537","journal-title":"J Hepatol"},{"issue":"11","key":"9691_CR41","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cgh.2012.08.010","volume":"10","author":"AC Yopp","year":"2012","unstructured":"Yopp AC, Subramanian M, Jain MK, et al. Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection. Clin Gastoenterol Hepatol 2012;10(11):1284\u20131290","journal-title":"Clin Gastoenterol Hepatol"},{"issue":"2","key":"9691_CR42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1148\/radiol.2015141500","volume":"277","author":"M Lewin","year":"2015","unstructured":"Lewin M, Gelu-Simeon M, Ostos M, et al. Imaging features and prognosis of hepatocellular carcinoma in patients with cirrhosis who are coinfected with human immunodeficiency virus and hepatitis C virus. Radiology 2015;277(2):443\u2013453","journal-title":"Radiology"},{"issue":"10","key":"9691_CR43","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/QAD.0000000000000300","volume":"28","author":"M Gelu-Simeon","year":"2014","unstructured":"Gelu-Simeon M, Sobesky R, Haim-Boukobza S, et al. Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIV-infected patients justify specific screening policies? AIDS 2014;28(10):1379\u20131391","journal-title":"AIDS"},{"issue":"2","key":"9691_CR44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","volume":"4","author":"M Omata","year":"2010","unstructured":"Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4(2):439\u2013474","journal-title":"Hepatol Int"},{"issue":"4","key":"9691_CR45","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association For The Study of The L, European Organisation For R, Treatment of C","year":"2012","unstructured":"European Association For The Study of The L, European Organisation For R, Treatment of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56(4):908\u2013943","journal-title":"J Hepatol"},{"issue":"4","key":"9691_CR46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cld.2014.07.002","volume":"18","author":"JG Abraldes","year":"2014","unstructured":"Abraldes JG, Sarlieve P, Tandon P. Measurement of portal pressure. Clin Liver Dis 2014;18(4):779\u2013792","journal-title":"Clin Liver Dis"},{"issue":"5","key":"9691_CR47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cid\/cit768","volume":"58","author":"L Perez-Latorre","year":"2014","unstructured":"Perez-Latorre L, Sanchez-Conde M, Rincon D, et al. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography. Clin Infect Dis 2014;58(5):713\u2013718","journal-title":"Clin Infect Dis"},{"issue":"7","key":"9691_CR48","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3851\/IMP2349","volume":"17","author":"T Reiberger","year":"2012","unstructured":"Reiberger T, Payer BA, Ferlitsch A, et al. A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV\u2013HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin. Antivir Ther 2012;17(7):1327\u20131334","journal-title":"Antivir Ther"},{"issue":"6","key":"9691_CR49","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/cid\/ciu939","volume":"60","author":"J Berenguer","year":"2015","unstructured":"Berenguer J, Zamora FX, Aldamiz-Echevarria T, et al. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2015;60(6):950\u2013958","journal-title":"Clin Infect Dis"},{"issue":"16","key":"9691_CR50","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1097\/QAD.0b013e32836381f3","volume":"27","author":"J Macias","year":"2013","unstructured":"Macias J, Camacho A, Von Wichmann MA, et al. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV\/hepatitis C virus-coinfected patients. AIDS 2013;27(16):2541\u20132549","journal-title":"AIDS"},{"issue":"6","key":"9691_CR51","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 2006;43(6):1317\u20131325","journal-title":"Hepatology"},{"issue":"3","key":"9691_CR52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2008.11.019","volume":"7","author":"C Tural","year":"2009","unstructured":"Tural C, Tor J, Sanvisens A, et al. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus. Clin Gastroneterol Hepatol 2009;7(3):339\u2013345","journal-title":"Clin Gastroneterol Hepatol"},{"issue":"8","key":"9691_CR53","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1572-0241.2008.01954.x","volume":"103","author":"MA Loko","year":"2008","unstructured":"Loko MA, Castera L, Dabis F, et al. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort. Am J Gastroenterol 2008;103(8):1973\u20131980","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"9691_CR54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gut.2005.065904","volume":"55","author":"J Macias","year":"2006","unstructured":"Macias J, Giron-Gonzalez JA, Gonzalez-Serrano M, et al. Prediction of liver fibrosis in human immunodeficiency virus\/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut 2006;55(3):409\u2013414","journal-title":"Gut"},{"issue":"4","key":"9691_CR55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2893.2009.01180.x","volume":"17","author":"M Sanchez-Conde","year":"2010","unstructured":"Sanchez-Conde M, Montes-Ramirez ML, Miralles P, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV\/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat 2010;17(4):280\u2013286","journal-title":"J Viral Hepat"},{"issue":"2","key":"9691_CR56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.qai.0000194238.15831.c7","volume":"41","author":"V Ledinghen de","year":"2006","unstructured":"de Ledinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV\/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006;41(2):175\u2013179","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"9691_CR57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/hep.25616","volume":"56","author":"N Merchante","year":"2012","unstructured":"Merchante N, Rivero-Juarez A, Tellez F, et al. Liver stiffness predicts clinical outcome in human immunodeficiency virus\/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Hepatology 2012;56(1):228\u2013238","journal-title":"Hepatology"},{"issue":"6","key":"9691_CR58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/apt.13315","volume":"42","author":"M Mandorfer","year":"2015","unstructured":"Mandorfer M, Kozbial K, Freissmuth C, et al. Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virologic responses. Aliment Pharmacol Ther 2015;42(6):707\u2013718","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"9691_CR59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"European Association for Study of L, Asociacion Latinoamericana para el Estudio del H","year":"2015","unstructured":"European Association for Study of L, Asociacion Latinoamericana para el Estudio del H. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63(1):237\u2013264","journal-title":"J Hepatol"},{"issue":"4","key":"9691_CR60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAD.0b013e328343443b","volume":"25","author":"European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel","year":"2011","unstructured":"European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel. Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference. AIDS 2011;25(4):399\u2013409","journal-title":"AIDS"},{"issue":"6","key":"9691_CR61","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/cid\/cit799","volume":"58","author":"DS Fierer","year":"2014","unstructured":"Fierer DS, Dieterich DT, Mullen MP, et al. Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men. Clin Infect Dis 2014;58(6):873\u2013879","journal-title":"Clin Infect Dis"},{"issue":"5","key":"9691_CR62","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/infdis\/jiu516","volume":"211","author":"M Mandorfer","year":"2015","unstructured":"Mandorfer M, Steiner S, Schwabl P, et al. Response-guided boceprevir-based triple therapy in HIV\/HCV-coinfected patients: the HIVCOBOC-RGT Study. J Infect Dis 2015;211(5):729\u2013735","journal-title":"J Infect Dis"},{"issue":"3","key":"9691_CR63","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2013.04.035","volume":"59","author":"C Hezode","year":"2013","unstructured":"Hezode C, Fontaine H, Dorival C, et al. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)\u2014NCT01514890. J Hepatol 2013;59(3):434\u2013441","journal-title":"J Hepatol"},{"issue":"5","key":"9691_CR64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ396","volume":"61","author":"B Simmons","year":"2015","unstructured":"Simmons B, Saleem J, Heath K, Cooke GS, Hill A. Long-term treatment outcomes of patients infected with Hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a Sustained Virological Response. Clin Infect Dis 2015;61(5):730\u2013740","journal-title":"Clin Infect Dis"},{"issue":"1","key":"9691_CR65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","volume":"63","author":"European Association for the Study of the Liver","year":"2015","unstructured":"European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2015. J Hepatol 2015;63(1):199\u2013236","journal-title":"J Hepatol"},{"key":"9691_CR66","unstructured":"Chung RT, Davis GL, Masur H, et al. Recommendations for testing, managing, and treating hepatitis C 2015 (16 Nov 2015). http:\/\/www.hcvguidelines.org\/full-report-view"},{"issue":"5","key":"9691_CR67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/apc.2013.0359","volume":"28","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer M, Payer BA, Niederecker A, et al. Therapeutic potential of and treatment with boceprevir\/telaprevir-based triple-therapy in HIV\/chronic hepatitis C co-infected patients in a real-world setting. AIDS Patient Care STDS 2014;28(5):221\u2013227","journal-title":"AIDS Patient Care STDS"},{"issue":"4","key":"9691_CR68","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.2014.7734","volume":"312","author":"MS Sulkowski","year":"2014","unstructured":"Sulkowski MS, Naggie S, Lalezari J, et al. Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. JAMA 2014;312(4):353\u2013361","journal-title":"JAMA"},{"issue":"9973","key":"9691_CR69","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(14)62483-1","volume":"385","author":"JM Molina","year":"2015","unstructured":"Molina JM, Orkin C, Iser DM, et al. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study. Lancet 2015;385(9973):1098\u20131106","journal-title":"Lancet"},{"issue":"8","key":"9691_CR70","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1056\/NEJMoa1503153","volume":"373","author":"DL Wyles","year":"2015","unstructured":"Wyles DL, Ruane PJ, Sulkowski MS, et al. Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. New Engl J Med 2015;373(8):714\u2013725","journal-title":"New Engl J Med"},{"issue":"4","key":"9691_CR71","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.27726","volume":"61","author":"DR Nelson","year":"2015","unstructured":"Nelson DR, Cooper JN, Lalezari JP, et al. All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology 2015;61(4):1127\u20131135","journal-title":"Hepatology"},{"issue":"12","key":"9691_CR72","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jama.2015.1373","volume":"313","author":"A Osinusi","year":"2015","unstructured":"Osinusi A, Townsend K, Kohli A, et al. Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. JAMA 2015;313(12):1232\u20131239","journal-title":"JAMA"},{"issue":"8","key":"9691_CR73","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1501315","volume":"373","author":"S Naggie","year":"2015","unstructured":"Naggie S, Cooper C, Saag M, et al. Ledipasvir and Sofosbuvir for HCV in patients coinfected with HIV-1. New Engl J Med 2015;373(8):705\u2013713","journal-title":"New Engl J Med"},{"issue":"12","key":"9691_CR74","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.2015.1328","volume":"313","author":"MS Sulkowski","year":"2015","unstructured":"Sulkowski MS, Eron JJ, Wyles D, et al. Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial. JAMA 2015;313(12):1223\u20131231","journal-title":"JAMA"},{"issue":"14","key":"9691_CR75","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/QAD.0000000000000787","volume":"29","author":"ACH Cohort","year":"2015","unstructured":"Cohort ACH. Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV\/HCV-coinfected patients. AIDS 2015;29(14):1821\u20131830","journal-title":"AIDS"},{"issue":"3","key":"9691_CR76","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jhep.2014.10.032","volume":"62","author":"JM Miro","year":"2015","unstructured":"Miro JM, Stock P, Teicher E, et al. Outcome and management of HCV\/HIV coinfection pre- and post-liver transplantation. A 2015 update. J Hepatol 2015;62(3):701\u2013711","journal-title":"J Hepatol"},{"issue":"2","key":"9691_CR77","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","volume":"47","author":"JC Duclos-Vallee","year":"2008","unstructured":"Duclos-Vallee JC, Feray C, Sebagh M, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008;47(2):407\u2013417","journal-title":"Hepatology"},{"issue":"7","key":"9691_CR78","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1600-6143.2012.04028.x","volume":"12","author":"JM Miro","year":"2012","unstructured":"Miro JM, Montejo M, Castells L, et al. Outcome of HCV\/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study. Am J Transpl 2012;12(7):1866\u20131876","journal-title":"Am J Transpl"},{"issue":"1","key":"9691_CR79","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2014.07.034","volume":"62","author":"L Castells","year":"2015","unstructured":"Castells L, Rimola A, Manzardo C, et al. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study. J Hepatol 2015;62(1):92\u2013100","journal-title":"J Hepatol"},{"issue":"1","key":"9691_CR80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/QAD.0000000000000516","volume":"29","author":"TM Antonini","year":"2015","unstructured":"Antonini TM, Furlan V, Teicher E, et al. Therapy with boceprevir or telaprevir in HIV\/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. AIDS 2015;29(1):53\u201358","journal-title":"AIDS."},{"issue":"3","key":"9691_CR81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","volume":"149","author":"M Charlton","year":"2015","unstructured":"Charlton M, Everson GT, Flamm SL, et al. Ledipasvir and Sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease. Gastroenterology 2015;149(3):649\u2013659","journal-title":"Gastroenterology"},{"issue":"25","key":"9691_CR82","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","volume":"371","author":"PY Kwo","year":"2014","unstructured":"Kwo PY, Mantry PS, Coakley E, et al. An interferon-free antiviral regimen for HCV after liver transplantation. New Engl J Med 2014;371(25):2375\u20132382","journal-title":"New Engl J Med"},{"issue":"6","key":"9691_CR83","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.23411","volume":"18","author":"NA Terrault","year":"2012","unstructured":"Terrault NA, Roland ME, Schiano T, et al. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl 2012;18(6):716\u2013726","journal-title":"Liver Transpl"},{"issue":"8","key":"9691_CR84","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1600-6143.2009.02684.x","volume":"9","author":"L Tricot","year":"2009","unstructured":"Tricot L, Teicher E, Peytavin G, et al. Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transpl 2009;9(8):1946\u20131952","journal-title":"Am J Transpl"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9691-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-015-9691-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9691-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T13:06:26Z","timestamp":1654088786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-015-9691-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,12]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["9691"],"URL":"https:\/\/doi.org\/10.1007\/s12072-015-9691-4","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,12]]}}}